DMIDX
Price
$27.86
Change
-$0.69 (-2.42%)
Updated
Feb 21 closing price
Net Assets
1.47B
VEXAX
Price
$144.57
Change
-$4.57 (-3.06%)
Updated
Feb 21 closing price
Net Assets
116.7B
Ad is loading...

DMIDX vs VEXAX

Header iconDMIDX vs VEXAX Comparison
Open Charts DMIDX vs VEXAXBanner chart's image
BNY Mellon MidCap Index I
Price$27.86
Change-$0.69 (-2.42%)
VolumeN/A
Net Assets1.47B
Vanguard Extended Market Index Admiral
Price$144.57
Change-$4.57 (-3.06%)
VolumeN/A
Net Assets116.7B
DMIDX vs VEXAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
DMIDX vs. VEXAX commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DMIDX is a Hold and VEXAX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
VEXAX has more cash in the bank: 117B vs. DMIDX (1.47B). DMIDX (1.21) and VEXAX (1.20) have matching dividends . DMIDX was incepted earlier than VEXAX: DMIDX (8 years) vs VEXAX (24 years). DMIDX is a more actively managed with annual turnover of: 17.50 vs. VEXAX (11.00). DMIDX has a lower initial minimum investment than VEXAX: DMIDX (1000) vs VEXAX (3000). VEXAX annual gain was more profitable for investors over the last year : 14.31 vs. DMIDX (-1.77). VEXAX return over 5 years is better than : 47.41 vs. DMIDX (-11.89).
DMIDXVEXAXDMIDX / VEXAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence8 years24 years-
Gain YTD-0.5360.340-157%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets1.47B117B1%
Annual Yield % from dividends1.211.20101%
Returns for 1 year-1.7714.31-12%
Returns for 3 years-12.8821.16-61%
Returns for 5 years-11.8947.41-25%
Returns for 10 yearsN/A115.96-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ALVO12.280.58
+4.96%
Alvotech
WEST6.350.10
+1.60%
Westrock Coffee Company
LPTX0.48N/A
-0.52%
Leap Therapeutics
LPLA372.13-7.33
-1.93%
LPL Financial Holdings
OPRX5.78-0.41
-6.62%
OptimizeRx Corp